Anti-CD45RB antibodies
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 4, 2007
Grant Date -
Dec 18, 2003
app pub date -
Dec 2, 2002
filing date -
Dec 3, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Antibodies which specifically recognize the human CD45 isoform RB are presented. These antibodies may be used to block undesirable immune reactions in patients with transplant rejection and autoimmune diseases such as rheumatoid arthritis, multiple sclerosis and autoimmune diabetes. Preferred antibodies are fully human, monoclonal antibodies.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully